These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6258534)

  • 1. [Autoantibodies in glioblastoma multiforme (author's transl)].
    Roda JE; Heredero JJ; Villarejo FJ; Roda JM
    Arch Neurobiol (Madr); 1980; 43(6):377-90. PubMed ID: 6258534
    [No Abstract]   [Full Text] [Related]  

  • 2. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells.
    Tang J; Flomenberg P; Harshyne L; Kenyon L; Andrews DW
    Clin Cancer Res; 2005 Jul; 11(14):5292-9. PubMed ID: 16033848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemistry of brain tumor--brain tumor protein and immune reactions (author's transl)].
    Takakura K
    No Shinkei Geka; 1974 Oct; 2(10):655-61. PubMed ID: 4373672
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunology of brain tumors: the glial carcino-fetal antigen].
    Trouillas P
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):819-28. PubMed ID: 4340548
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunology and immunotherapy of cerebral tumors. Current status].
    Trouillas P
    Rev Neurol (Paris); 1973 Jan; 128(1):23-38. PubMed ID: 4367367
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary brain tumors: tumor immunity and immunocompetence.
    Mavligit GM; Gutterman JU; Hersh EM
    Surg Neurol; 1973 Sep; 1(5):261-3. PubMed ID: 4353433
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival.
    Pallasch CP; Struss AK; Munnia A; König J; Steudel WI; Fischer U; Meese E
    Int J Cancer; 2005 Nov; 117(3):456-9. PubMed ID: 15906353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses in patients with gliomas.
    Brooks WH; Caldwell HD; Mortara RH
    Surg Neurol; 1974 Nov; 2(6):419-23. PubMed ID: 4372736
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of immunologic studies in malignant tumors of the human brain].
    Romodanov AP; Lisianyĭ NI; Prikhodchenko IA
    Zh Vopr Neirokhir Im N N Burdenko; 1983; (3):56-9. PubMed ID: 6310917
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunohistochemical study of the expression of proliferating cell nuclear antigen in astrocytic gliomas of the cerebral hemispheres].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1996; 58(2):32-7. PubMed ID: 8712938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific membrane antigens in established cell lines from gliomas.
    Wahlström T; Linder E; Saksela E; Westermark B
    Cancer; 1974 Aug; 34(2):274-9. PubMed ID: 4369403
    [No Abstract]   [Full Text] [Related]  

  • 12. Why are systemic glioblastoma metastases rare? Systemic and cerebral growth of mouse glioblastoma.
    Mourad PD; Farrell L; Stamps LD; Chicoine MR; Silbergeld DL
    Surg Neurol; 2005 Jun; 63(6):511-9; discussion 519. PubMed ID: 15936366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extracranial metastasis of the glioblastoma multiforme--an ultrastructural studies (author's transl)].
    Shimura T; Itoh Y; Nakazawa S; Yamada N; Aihara K
    No To Shinkei; 1980 Jun; 32(6):601-9. PubMed ID: 6257263
    [No Abstract]   [Full Text] [Related]  

  • 14. Two specific antigens in glioblastoma multiforme identified by monoclonal antibodies.
    Sharma SK; Kochhar KS; Sharma E; Thapliyal RM; Singh UN
    Indian J Biochem Biophys; 1988; 25(1-2):185-92. PubMed ID: 2846427
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble membrane antigens of brain tumors. I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient.
    Hitchcock MH; Hollinshead AC; Chretien P; Rizzoli HV
    Cancer; 1977 Aug; 40(2):660-6. PubMed ID: 196738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glial tumors of the brain: current aspects of the immunopathogenesis and immunogenodiagnosis].
    Anan'eva II; Malkarov MS; Korsakova NA; Dorofeev AE; Kachkov IA; Suchkov SV; Balkanov AS
    Arkh Patol; 2007; 69(2):53-7. PubMed ID: 17642197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.
    Yu JS; Wheeler CJ; Zeltzer PM; Ying H; Finger DN; Lee PK; Yong WH; Incardona F; Thompson RC; Riedinger MS; Zhang W; Prins RM; Black KL
    Cancer Res; 2001 Feb; 61(3):842-7. PubMed ID: 11221866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock proteins in glioblastomas.
    Yang I; Fang S; Parsa AT
    Neurosurg Clin N Am; 2010 Jan; 21(1):111-23. PubMed ID: 19944971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems peculiar to brain malignancies.
    Ramamurthi B
    Indian J Cancer; 1972 Sep; 9(3):249-50. PubMed ID: 4347920
    [No Abstract]   [Full Text] [Related]  

  • 20. [Frequency and significance of lymphoplasmocyte infiltration in human gliomas (author's transl)].
    Schiffer D; Croveri G; Pautasso C
    Tumori; 1974; 60(3):177-84. PubMed ID: 4372756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.